Spinal muscular atrophy type II skeletal muscle treated with Nusinersen and Risdiplam shows SMN restoration but mitochondrial deficiency

被引：0
|
作者：
Grandi, F. [1 ]
Astord, S. [1 ]
Pezet, S. [1 ]
Gidaja, E. [1 ]
Mazzucchi, S. [1 ]
Chapart, M. [1 ]
Vasseur, S. [1 ]
Mamchaoui, K. [1 ]
Smeriglio, P. [1 ]
机构：
[1] INSERM, UMR 974, Paris, France
来源：
NEUROMUSCULAR DISORDERS | 2024年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
178P
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Respiratory management of spinal muscular atrophy type 1 patients treated with Nusinersen
    Menard, Joris
    Seferian, Andreea M.
    Fleurence, Emmanuelle
    Barzic, Audrey
    Binoche, Alexandra
    Labouret, Geraldine
    Coutier, Laurianne
    Vuillerot, Carole
    Bieleu, Blaise M.
    de la Banda, Marta Gomez Garcia
    Corvol, Harriet
    Servais, Laurent
    Taytard, Jessica
    PEDIATRIC PULMONOLOGY, 2022, 57 (06) : 1505 - 1512
  • [12] Clinical Outcomes in Patients with Spinal Muscular Atrophy Type 1 Treated with Nusinersen
    Mendonca, Rodrigo de Holanda
    Polido, Graziela Jorge
    Matsui, Ciro, Jr.
    Fontoura Solla, Davi Jorge
    Reed, Umbertina Conti
    Zanoteli, Edmar
    JOURNAL OF NEUROMUSCULAR DISEASES, 2021, 8 (02) : 217 - 224
  • [13] COST-EFFECTIVENESS OF RISDIPLAM VERSUS NUSINERSEN FOR TREATING PATIENTS WITH SPINAL MUSCULAR ATROPHY TYPE 1 IN CHINA
    Hu, J.
    Sutherland, C. S.
    Ribero, Aponte, V
    Zhu, L.
    Hou, X.
    Xia, Y.
    Tang, M.
    Jin, C.
    Kang, Q.
    VALUE IN HEALTH, 2022, 25 (01) : S105 - S105
  • [14] Long-Term Comparative Efficacy and Safety of Risdiplam and Nusinersen in Children with Type 1 Spinal Muscular Atrophy
    Kokaliaris, Christos
    Evans, Rachel
    Hawkins, Neil
    Mahajan, Anadi
    Scott, David Alexander
    Sutherland, C. Simone
    Nam, Julian
    Sajeev, Gautam
    ADVANCES IN THERAPY, 2024, 41 (06) : 2414 - 2434
  • [15] A severely affected adult type 2 spinal muscular atrophy patient treated with risdiplam
    Schon, Miguel
    Domingues, Sara
    Moreno, Teresa
    Santos, Miguel Oliveira
    NEUROLOGICAL SCIENCES, 2023, 44 (04) : 1449 - 1450
  • [16] A severely affected adult type 2 spinal muscular atrophy patient treated with risdiplam
    Miguel Schön
    Sara Domingues
    Teresa Moreno
    Miguel Oliveira Santos
    Neurological Sciences, 2023, 44 : 1449 - 1450
  • [17] Skeletal muscle dysfunction and mitochondrial deficits in spinal muscular atrophy (SMA)
    Hellbach, N.
    McCarthy, K. D.
    Saenger, S.
    Peterson, S.
    Schmidt, U.
    Paushkin, S.
    Czech, C.
    Metzger, F.
    NEUROMUSCULAR DISORDERS, 2017, 27 : S30 - S30
  • [18] Skeletal Muscle Mitochondrial and Autophagic Dysregulation Are Modifiable in Spinal Muscular Atrophy
    Mikhail, Andrew I.
    Ng, Sean Y.
    Xhuti, Donald
    Lesinski, Magda A.
    Chhor, Jennifer
    Deguise, Marc-Olivier
    De Repentigny, Yves
    Nederveen, Joshua P.
    Kothary, Rashmi
    Tarnopolsky, Mark A.
    Ljubicic, Vladimir
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2025, 16 (01)
  • [19] Spinal muscular atrophy type II with hybrid SMN gene: A case report
    Khosidik, Antoni
    Harahap, Indra Sari Kusuma
    Sutarni, Sri
    Setyaningrum, Cempaka Thursina Srie
    Setyaningsih, Indarwati
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [20] Cost-Effectiveness of Onasemnogene Abeparvovec Compared With Nusinersen and Risdiplam in Patients With Spinal Muscular Atrophy Type 1 in Brazil
    Fernandes, Brigida Dias
    Rodrigues, Fernanda D'Athayde
    Cirilo, Herica Nubia Cardoso
    Borges, Stefani Sousa
    Krug, Barbara Correa
    Probst, Livia Fernandes
    Zimmermann, Ivan
    VALUE IN HEALTH REGIONAL ISSUES, 2024, 40 : 108 - 117
12345